Target intelligence / Profile preview

Spindlin interactor and repressor of chromatin-binding protein (SPINDOC)

Target
SPINDOC
Molecular classification
Chromatin-associated protein, Epigenetic cofactor, Other
01

Overview

Spindlin interactor and repressor of chromatin-binding protein (SPINDOC, also known as C11orf84, SPIN-DOC, and SPIN1-docking protein) is a chromatin-associated protein that regulates the functions of the epigenetic reader Spindlin1. SPINDOC forms distinct protein complexes either with Spindlin1 or with PARP1, regulating pathways related to transcription and the DNA damage response[1][2][3]. By binding to Spindlin1, SPINDOC blocks Spindlin1’s ability to "read" the H3K4me3 histone mark, disassociating it from chromatin and acting as a transcriptional repressor[3]. In complex with Spindlin1, SPINDOC (C11orf84) plays a key role in recognizing non-canonical bivalent histone marks (H3K4me3K9me3) on rDNA loci, thereby regulating ribosomal RNA transcription and cell proliferation[2][4]. SPINDOC also directly interacts with PARP1 and promotes DNA repair-associated PARylation, indicating a role in genome maintenance under cellular stress[1]. While there is emerging evidence for SPINDOC’s roles in cancer and cell proliferation, SPINDOC is not currently considered a direct therapeutic target, and no known drugs interact directly with it.

Other names
C11orf84SPIN-DOCSPIN1-docking proteinhypothetical protein BC007540uncharacterized protein C11orf84
02

Biological functions

Chromatin regulationHistone modification recognitionTranscriptional repressionTranscription cofactor modulationDNA damage response
03

Disease associations

Cancer (implicated via regulation of transcriptional programs and DNA damage response)Other

Beyond the preview

Go deeper on Spindlin interactor and repressor of chromatin-binding protein (SPINDOC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spindlin interactor and repressor of chromatin-binding protein (SPINDOC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call